P1089 (DAIDS ID 11670): A Laboratory Study to Assess the Immunogenicity of Three Licensed Influenza A (H1N1) 2009 Monovalent Vaccines in HIV-1 Perinatally Infected Children and Youth

Study Status Study Restriction

Concluded

United States

What is P1089?

P1089 was a laboratory immunogenicity study designed to describe the short term immune response following immunization with a licensed Influenza A (H1N1) 2009 Monovalent Vaccine administered as a single dose in perinatally HIV-1 infected children and youth aged >10 to <25 years and to describe the short term immune response following second immunization with a licensed Influenza A (H1N1) 2009 Monovalent Vaccine in perinatally HIV-1 infected children > 6 months to < 10 years of age.

Sites where the study was implemented:

CRS ID Site Name City Country

4001

Chicago Children's CRS

Chicago

United States of America

5083

Rush University Cook County Hospital Chicago NICHD CRS

Chicago

United States of America

Study contacts:

No records returned.

CTS: IMPAACT Operations Center

 

Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.